Stimlabs(R) LLC Announces Launch of Relese(R) - A Uniquely Fenestrated Allograft for Chronic and Acute Wounds

ROSWELL, Ga., Aug. 24, 2023 -- (Healthcare Sales & Marketing Network) -- Stimlabs LLC, ("StimLabs"), a leader in regenerative medicine, announced the launch of Relese, a fenestrated dehydrated complete human placental membrane (dCHPM) allograft ... Devices, Regenerative Medicine, Wound Care, Product Launch Stimlabs, Relese, human placental membrane, allograft
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news